Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Increasing the Effectiveness and Diffusion of COVID-19 Messaging for Vaccination

NCT05182554 is registered in ClinicalTrials.gov with Massachusetts Institute of Technology as lead sponsor.

NCT NCT05182554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05182554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Increasing the Effectiveness and Diffusion of COVID-19 Messaging for Vaccination
Lead sponsor
Massachusetts Institute of Technology
Phase
Not applicable
Overall status
Completed
Start date
December 22, 2021
Completion date
January 27, 2022
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pandemic, vaccination refusal